We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




New Breast Implants Contain RFID Technology

By HospiMedica International staff writers
Posted on 02 Mar 2014
Print article
Image: The Q Inside Safety Technology RFID chip (Photo courtesy of VeriTeQ Corporation).
Image: The Q Inside Safety Technology RFID chip (Photo courtesy of VeriTeQ Corporation).
Breast implants with radiofrequency identification (RFID) chips can be simply externally scanned for retrieval of information in the event of a recall or other product query.

The Motiva Implant Matrix VelvetSurface PLUS and SilkSurface PLUS breast implants are a made of a soft, gliding, printed nanosurface that reduces complications related to traditional textures, while at the same time reducing capsular contracture rates. The VelvetSurface PLUS implants also provide a printed microsurface that promotes a more secure fit in the breast pocket. Both breast implants are provided with Q Inside Safety Technology, which acts as an electronic serial identification number in breast implants and other implantable and reusable medical devices.

Manufacturers, physicians, and patients alike will have access to a secure online database to retrieve implant-specific data such as serial number, manufacturer name, date of manufacture, lot number, volume, size, and other data from the medical device manufacturer. The Motiva Implant Matrix VelvetSurface PLUS and SilkSurface PLUS breast implants are products of Establishment Labs (Alajuela, Costa Rica). Q Inside Safety Technology was developed by VeriTeQ Corporation (DelRay Beach, FL, USA), a provider of implantable medical device identification and radiation dose measurement technologies.

“We continue to advance the safety and exclusivity of our entire breast implant portfolio to answer the demands from both physicians and patients alike,” said Juan José Chacón-Quirós, CEO of Establishment Labs. “Including VeriTeQ’s Q Inside Safety Technology in Motiva’s SilkSurface PLUS and VelvetSurface PLUS implants emphasizes our primary focus of providing best-in-class products for the protection of the patient.”

“Giving physicians and patients the power to identify their breast implants in a healthcare setting is the next generation of technology and security, and we believe both groups will ultimately demand this level of safety from their implants,” said Scott R. Silverman, chairman and CEO of VeriTeQ.

A example highlighting the need for breast implant identification occurred in 2010, when a French manufacturer of breast implants named PIP was shut down because the company used industrial grade silicone in their implants instead of medical-grade silicone, which had double the rupture rate of other implants. As news of leaks spread, breast implant patients were concerned that they may have PIP's implants. Many of the patients did not have product or warranty cards, and no records were available on which implants were inside each patient.

Related Links:

Establishment Labs
VeriTeQ Corporation


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Vital Signs Monitor
iM3s
New
Video Uretero-Renoscope
Olympus URF-V3/V3R

Print article

Channels

Surgical Techniques

view channel
Image: The stretchy hydrogel and a vial of liquid polymer (Photo courtesy of WPI)

New Class of Bioadhesives to Connect Human Tissues to Long-Term Medical Implants

Medical devices and human tissues differ significantly in their composition. While medical devices are primarily constructed from hard materials like metal and plastic, human tissue is soft and moist.... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.